Recently, naturally processed and presented epitopes (NPPEs) derived from S100-β, restricted by the HLA-DRB1*04:01 (HLA-DR4) class II molecule, and targeted by the autoimmune response in T1D patients have been identified (23). This evidence concerns the gene S100B and type 1 diabetes mellitus.